Seasoned investor and operator with cross-border experience in growth-stage technology and healthcare companies. Malgorzata Serafin has led strategy, corporate development and M&A initiatives and worked with buyouts, minority growth investments and operational turnarounds. She brings a finance-oriented approach to portfolio value creation, board-level governance and exit planning, and typically engages with founders, PE sponsors and corporate acquirers.
Seasoned investor and operator with cross-border experience in growth-stage technology and healthcare companies. Malgorzata Serafin has led strategy, corporate development and M&A initiatives and worked with buyouts, minority growth investments and operational turnarounds. She brings a finance-oriented approach to portfolio value creation, board-level governance and exit planning, and typically engages with founders, PE sponsors and corporate acquirers.
Combines a finance-driven, operational lens to back growth-stage technology and healthcare companies across borders, prioritizing investments where strategic M&A, corporate development and governance can accelerate scale and exit value. Targets minority growth and control-oriented situations where board engagement, operational turnarounds and disciplined capital allocation unlock EBITDA improvement. Deploys medium-to-long horizon capital with rigorous due diligence, clear value-creation milestones and scenario-based risk sizing. Favors assets with strong founder alignment or sponsor partnerships, differentiated product-market fit and predictable regulatory pathways. Competitive edge lies in marrying dealcraft and execution—crafting integration plans, reinforcing commercial execution and shaping exit routes to capture multiple expansion.
Combines a finance-driven, operational lens to back growth-stage technology and healthcare companies across borders, prioritizing investments where strategic M&A, corporate development and governance can accelerate scale and exit value. Targets minority growth and control-oriented situations where board engagement, operational turnarounds and disciplined capital allocation unlock EBITDA improvement. Deploys medium-to-long horizon capital with rigorous due diligence, clear value-creation milestones and scenario-based risk sizing. Favors assets with strong founder alignment or sponsor partnerships, differentiated product-market fit and predictable regulatory pathways. Competitive edge lies in marrying dealcraft and execution—crafting integration plans, reinforcing commercial execution and shaping exit routes to capture multiple expansion.
| Trades 3517 | Longs Won 2258/3517 64% | Profit Factor 4.82 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.29M |
| Average Win $579,588.55 | Best Trade (Oct 15) $21.66M | Sharpe Ratio -46.86 |
| Average Loss -$215,827.91 | Worst Trade (Mar 31) -$6M | Z-Score 3.88 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 2w 4d | Expectancy $294,848.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,579 | 5,921 | 5,263 | 4,605 | 3,947 | 3,289 | 2,632 | 1,974 | 1,316 | 658 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 4,000 | $463,420 | $694,680 | - | $231,260 | 49.9% | -1.071% |
AAPL Apple Inc. | 170,000 | $36.9M | $58.68M | - | $21.77M | 59% | +0.927% |
ABBV AbbVie Inc. | 21,200 | $3.95M | $6.03M | - | $2.08M | 52.64% | +0.314% |
ABNB Airbnb, Inc. | 11,000 | $1.34M | $1.92M | - | $588,830 | 44.09% | +0.384% |
ABT Abbott Laboratories | 21,000 | $2.85M | $2.19M | - | -$658,829.67 | -23.1% | -0.229% |
ADBE Adobe Inc. | 15,000 | $6.41M | $3.68M | - | -$2.73M | -42.56% | -2.456% |
ADI Analog Devices, Inc. | 17,000 | $4.15M | $6.94M | - | $2.79M | 67.18% | +1.025% |
ADM Archer-Daniels-Midland Co | 15,150 | $1.13M | $1.25M | - | $127,044.02 | 11.27% | -0.157% |
ADP Automatic Data Processing Inc. | 13,000 | $3.75M | $3.73M | - | -$18,829.88 | -0.5% | +0.515% |
ADSK Autodesk, Inc. | 7,000 | $2.08M | $1.68M | - | -$396,806.47 | -19.11% | -2.146% |
AEM Agnico Eagle Mines Limited | 203,120 | $15.74M | $38.34M | - | $22.59M | 143.49% | +0.629% |
AEP American Electric Power Company, Inc. | 17,000 | $2.33M | $2.15M | - | -$173,145 | -7.44% | +1.879% |
AG First Majestic Silver Corp | 243,706 | $2.74M | $3.92M | - | $1.17M | 42.79% | -0.155% |
AGI Alamos Gold Inc. | 198,363 | $3.71M | $6.34M | - | $2.63M | 70.96% | +0.016% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 5,000 | $2.42M | $1.44M | - | -$970,500 | -40.18% | -4.325% |
ALNY Alnylam Pharmaceuticals Inc | 7,500 | $2.96M | $1.76M | - | -$1.2M | -40.45% | +0.466% |
AMAT Applied Materials, Inc. | 26,000 | $4.83M | $10.85M | - | $6.01M | 124.4% | -2.956% |
AMD Advanced Micro Devices, Inc. | 53,000 | $6.25M | $28.75M | - | $22.5M | 359.93% | -3.504% |
AMGN Amgen Inc. | 16,400 | $4.59M | $7.15M | - | $2.57M | 55.9% | +0.511% |
AMZN Amazon.com Inc | 143,000 | $27.26M | $36.26M | - | $9M | 33.03% | -0.467% |